Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
- Generic Name
- Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
- Brand Names
- Adacel, Boostrix, Daptacel, Diphtheria and Tetanus Toxoids Adsorbed, Infanrix, Kinrix, Pediarix, Pentacel, Quadracel, Td Adsorbed, Tdvax, Tenivac, Vaxelis
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 308079-75-6
- Unique Ingredient Identifier
- IRH51QN26H
- Associated Conditions
- Diphtheria, Tetanus
- Associated Therapies
- -
PFAS Exposure and Immune Response to Vaccination in Adults
Phase 4
Not yet recruiting
- Conditions
- Innate Inflammatory ResponseVaccinationDiphtheriaTetanusEnvironmental ExposureVaccineAntibodiesAdultImmunityPollution; Exposure
- Interventions
- First Posted Date
- 2024-09-09
- Last Posted Date
- 2024-09-09
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 20
- Registration Number
- NCT06588530
- Locations
- 🇺🇸
EOHSI Paulsboro Office, Paulsboro, New Jersey, United States
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Phase 3
Active, not recruiting
- Conditions
- Infections, Meningococcal
- Interventions
- Biological: Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ)Biological: Prevnar13Biological: PediarixBiological: HiberixBiological: M-M-R IIBiological: RotarixBiological: VarivaxBiological: Placebo (saline water)Biological: Prevnar 20
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1200
- Registration Number
- NCT03621670
- Locations
- 🇵🇷
GSK Investigational Site, San Juan, Puerto Rico
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath